Ann Childress
Child & Adolescent Psychiatry · Las Vegas, NVNPI 1457303828
Payments from drug & device makers
Across 1,420 payments — averaging $2536.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tris Pharma Inc$812K
- Supernus Pharmaceuticals, Inc.$678K
- Adlon Therapeutics L.p.$577K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$315K
- Corium, LLC$276K
- Purdue Pharma L.p.$235K
- plus $710K from 21 others
Across 66 payments — averaging $1609.30 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Purdue Pharma L.p.$79K
- Arbor Pharmaceuticals, Inc.$18K
- Supernus Pharmaceuticals, Inc.$3K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$2K
- Acadia Pharmaceuticals Inc$1K
- Neos Therapeutics, LP$1K
- plus $2K from 2 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tris Pharma Inc | 75 | $811,524 |
| Supernus Pharmaceuticals, Inc. | 514 | $677,732 |
| Adlon Therapeutics L.p. | 25 | $577,001 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 80 | $315,070 |
| Corium, LLC | 94 | $275,971 |
| Purdue Pharma L.p. | 20 | $234,756 |
| Takeda Pharmaceuticals U.S.A., Inc. | 190 | $150,759 |
| Ironshore Pharmaceuticals Inc. | 209 | $147,795 |
| Acadia Pharmaceuticals Inc | 30 | $131,173 |
| AbbVie(2 entities) | 21 | $94,562 |
| Collegium Pharmaceutical, Inc. | 44 | $69,121 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $22,643 |
| Vanda Pharmaceuticals Inc. | 2 | $15,821 |
| Vertical Pharmaceuticals, LLC | 3 | $15,571 |
| Shire North American Group Inc | 13 | $13,353 |
| Noven Pharmaceuticals, Inc. | 6 | $9,753 |
| Sunovion Pharmaceuticals Inc. | 48 | $9,660 |
| Neos Therapeutics, LP | 20 | $8,880 |
| Institut DE Recherches Internationales Servier | 2 | $8,182 |
| Rhodes Pharmaceuticals L.p. | 4 | $6,384 |
| Arbor Pharmaceuticals, Inc. | 1 | $2,520 |
| Otsuka America Pharmaceutical, Inc. | 1 | $1,800 |
| Noven Therapeutics, LLC | 2 | $1,100 |
| Sumitomo Pharma America, Inc. | 7 | $350 |
| Neurocrine Biosciences, Inc. | 2 | $235 |
| Alkermes, Inc. | 1 | $123 |
| MDD US Operations, LLC | 1 | $107 |
How this compares
$3,601,948 in reported general payments places this provider in the 95th percentile of 26 child & adolescent psychiatry providers in Nevada.
Other child & adolescent psychiatry in Las Vegas
- Joan CarapucciLas Vegas$7K
- Emmanuel NwapaLas Vegas$7K
- Rosa BellotaLas Vegas$1K
- Michelle Fontenelle-GilmerLas Vegas$904
- Corydon ClarkLas Vegas$777
- Nina ParikhLas Vegas$516
- Fernando MendezLas Vegas$249
- Colin FreedmanLas Vegas$198
- Olayinka HardingLas Vegas$16
- Jerome NwokikeNorth Las Vegas$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.